USPTO serial 79201890
AMRYT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SEVERSON, KAREN
- Law office
- LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with AMRYT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of epidermolysis bullosa, dermatological diseases and disorders, acromegaly, endocrine disorders, neuroendocrine disorders, Cushing's Disease, tumors, homozygous familial hypercholesterolemia, high blood cholesterol, metabolic diseases and disorders, infectious diseases, immune system diseases and disorders, blood diseases and disorders, oncological diseases and disorders, genitourinary diseases and disorders, pain, inflammatory and autoimmune diseases and disorders, gastrointestinal diseases and disorders, neurological diseases and disorders, respiratory diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders and pharmaceutical preparations for destroying parasites | ACTIVE | — |
| 010 | Medical devices, namely, medical syringes, inhalers for medical use, drug delivery patches sold without medication, infusion and injection devices for administering drugs | ACTIVE | — |
| 042 | Medical and pharmaceutical research; scientific services in the medical and pharmaceutical field, namely, pharmaceutical drug development services; pharmaceutical research, namely, conducting clinical trials for others in the field of pharmaceutical | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 24, 2023 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jul 30, 2023 | RHRD | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED | — |
| Jul 19, 2022 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jun 11, 2022 | RHRD | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED | — |
| May 17, 2022 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| May 8, 2022 | RHRD | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED | — |
| Jan 7, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 8, 2021 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Sep 19, 2021 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Sep 24, 2020 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Sep 11, 2020 | RHRD | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED | — |
| Jul 9, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 31, 2019 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 10, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 10, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 10, 2018 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 25, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 25, 2018 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 10, 2018 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 10, 2018 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 12, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 12, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 12, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 15, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 15, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 13, 2017 | ALIE | ASSIGNED TO LIE | — |
| Sep 8, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 7, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 25, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 7, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 7, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 4, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 3, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 28, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 27, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 24, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 23, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |